Acid reflux drugs linked to heightened risk of premature death in new study
Proton pump inhibitors used to reduce stomach acid levels and treat ulcers under scrutiny after latest findings published
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Drugs used to treat acid reflux have been linked to a heightened risk of premature death in a new study.
Proton pump inhibitors (PPIs) reduce the amount of acid made by the stomach and are used to treat acid reflux and stomach ulcers.
A team of US researchers performed a longitudinal observational study on data from the US Department of Veterans Affairs.
Over a follow-period of almost six years, they examined data on 3,288,092 people to compare users and non-users of PPIs.
Their study, published in the journal BMJ Open, also examined data on 349,312 people to compare risk of death between those taking PPIs with those taking another type of drug used to dampen down acid production called histamine H2 receptor antagonists, or H2 blockers.
They also looked at data on 2,887,030 people to assess risk of premature death for PPI users compared to PPI and no H2 blockers.
Compared with H2 blocker use, PPI use was associated with a 25% heightened risk of death from all causes.
They also found an increased risk of death when considering PPI use versus no PPI and an increased risk from PPI use versus no PPI and no H2 blocker use.
The study is an observational one, so no firm conclusions can be drawn about cause and effect, and the authors stress that the findings may not be extended generally because the majority of participants were older, white male veterans.
But they still caution that: “Limiting PPI use and duration to instances where it is medically indicated may be warranted.”
Press Association
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments